Collins Helen Louise
CIK 1701247
Transactions on file
27
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-21 | 2026-10-19 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 5,000 | $192.3K | +15.0% | open → |
| 2026-10-21 | 2026-10-19 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Exer. | 5,000 | $12.4K | +1684.3% | open → |
| 2026-09-21 | 2026-09-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 240 | $12.4K | -14.0% | open → |
| 2026-09-21 | 2026-09-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 1,844 | $93.5K | -12.7% | open → |
| 2026-09-21 | 2026-09-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 2,916 | $145.9K | -11.6% | open → |
| 2026-09-21 | 2026-09-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Exer. | 5,000 | $12.4K | +1684.3% | open → |
| 2026-08-19 | 2026-08-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 1,100 | $65.3K | -25.4% | open → |
| 2026-08-19 | 2026-08-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 3,900 | $227.6K | -24.2% | open → |
| 2026-08-19 | 2026-08-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Exer. | 5,000 | $12.4K | +1684.3% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 63 | $3.4K | -17.9% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 2,184 | $116.7K | -17.2% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 2,063 | $108.1K | -15.5% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 459 | $23.7K | -14.2% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 231 | $11.6K | -11.6% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Exer. | 5,000 | $12.4K | +1684.3% | open → |
| 2026-06-22 | 2026-06-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 1,133 | $50.7K | -1.1% | open → |
| 2026-06-22 | 2026-06-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 2,599 | $114.0K | +0.9% | open → |
| 2026-06-22 | 2026-06-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 1,268 | $54.3K | +3.3% | open → |
| 2026-06-22 | 2026-06-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Exer. | 5,000 | $12.4K | +1684.3% | open → |
| 2026-05-20 | 2026-05-18 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 223 | $9.2K | +7.4% | open → |
| 2026-05-20 | 2026-05-18 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 1,302 | $52.4K | +9.9% | open → |
| 2026-05-20 | 2026-05-18 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 3,475 | $137.4K | +11.9% | open → |
| 2026-05-20 | 2026-05-18 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Exer. | 5,000 | $12.4K | +1684.3% | open → |
| 2026-04-21 | 2026-04-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 2,441 | $117.3K | -7.9% | open → |
| 2026-04-21 | 2026-04-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 2,419 | $114.6K | -6.6% | open → |
| 2026-04-21 | 2026-04-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sale | 140 | $6.4K | -3.4% | open → |
| 2026-04-21 | 2026-04-17 | ELVN Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Exer. | 5,000 | $12.4K | +1684.3% | open → |
